Infusion of iloprost, a prostacyclin analogue, for treatment of Raynaud's phenomenon in systemic sclerosis.
about
Iloprost suppresses connective tissue growth factor production in fibroblasts and in the skin of scleroderma patientsQuantifying digital vascular disease in patients with primary Raynaud's phenomenon and systemic sclerosis.A double blind, randomised, multicentre comparison of two doses of intravenous iloprost in the treatment of Raynaud's phenomenon secondary to connective tissue diseases.Advances in the treatment of Raynaud's phenomenon.Gene expression profiling in circulating endothelial cells from systemic sclerosis patients shows an altered control of apoptosis and angiogenesis that is modified by iloprost infusion.Raynaud's syndromeRetrospective analysis of the frequency of centrofacial telangiectasia in systemic sclerosis patients treated with bosentan or ilomedin.The contribution of platelets to the pathogenesis of Raynaud's phenomenon and systemic sclerosis.Cytokines in the immunopathology of systemic sclerosis.Comparison between iloprost and alprostadil in the treatment of Raynaud's phenomenon.Treprostinil for the treatment of severe digital necrosis in systemic sclerosis.Meta-analysis of healing and prevention of digital ulcers in systemic sclerosis.Raynaud's syndrome, an enigma after 130 years.Halofuginone inhibition of COL1A2 promoter activity via a c-Jun-dependent mechanism.Efficacy and Safety of Selexipag in Adults With Raynaud's Phenomenon Secondary to Systemic Sclerosis: A Randomized, Placebo-Controlled, Phase II Study.A multi-national qualitative research study exploring the patient experience of Raynaud's phenomenon in systemic sclerosis.
P2860
Q28344134-8D0806BB-4997-4B82-8D95-B26C2D7F528DQ32061923-D6B92559-EF62-4034-999E-E92F6AC4F3D5Q33564034-789C4B01-E688-47C4-B39D-B4B1B36FDC5CQ33813778-11FAE466-B7AB-4875-88D1-4A3B437622EEQ34152945-FCBB3C45-D68F-4E39-9030-CF0ACADDDAE1Q35168169-E9E6B4DB-54E8-4A4C-85F4-3F24EF2F4425Q37515708-71FB79A2-BBE8-40CB-B9DF-91A05254B1C4Q38042445-48E83B18-A2D3-4967-99F0-E949E81A35AFQ38543692-C6AA4CBE-891B-4CB6-98B3-27BB0E5AF5CFQ39694879-F91CB4D0-F8EB-46AD-AE8A-318B0748A94BQ39718230-FFE271CD-4689-4E31-956E-01D189D877F7Q40102688-CC022642-3526-4CE2-A990-D62DEF9277BCQ40880698-13230990-AA0C-4CDA-A55E-5FE8D57F6351Q42526981-E6A2884E-99CB-4482-94A7-B7259C6DC941Q47591657-2C555D68-546E-45D6-B0FC-A7A27D20699DQ52374296-41735416-F65F-4904-A11D-6C3893DFF4FF
P2860
Infusion of iloprost, a prostacyclin analogue, for treatment of Raynaud's phenomenon in systemic sclerosis.
description
1988 nî lūn-bûn
@nan
1988 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1988 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
name
Infusion of iloprost, a prosta ...... nomenon in systemic sclerosis.
@ast
Infusion of iloprost, a prosta ...... nomenon in systemic sclerosis.
@en
Infusion of iloprost, a prosta ...... nomenon in systemic sclerosis.
@nl
type
label
Infusion of iloprost, a prosta ...... nomenon in systemic sclerosis.
@ast
Infusion of iloprost, a prosta ...... nomenon in systemic sclerosis.
@en
Infusion of iloprost, a prosta ...... nomenon in systemic sclerosis.
@nl
prefLabel
Infusion of iloprost, a prosta ...... nomenon in systemic sclerosis.
@ast
Infusion of iloprost, a prosta ...... nomenon in systemic sclerosis.
@en
Infusion of iloprost, a prosta ...... nomenon in systemic sclerosis.
@nl
P2093
P2860
P356
P1476
Infusion of iloprost, a prosta ...... nomenon in systemic sclerosis.
@en
P2093
Maddison PJ
P2860
P356
10.1136/ARD.47.1.43
P407
P577
1988-01-01T00:00:00Z